Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th Oct 23, 2023 7:30am EDT
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference Oct 16, 2023 7:30am EDT
Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference Aug 24, 2023 7:30am EDT
Aptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023 Jul 27, 2023 4:04pm EDT
